创伤性颈内动脉颅内段假性动脉瘤的血管内治疗
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家重点研发计划(2016YFC1300700),国家自然科学基金(81671137,81571126,8187093),2016年中国脑卒中高危人群干预适宜技术研究及推广项目(GN-2016R0012).


Endovascular treatment of traumatic intracranial internal carotid artery pseudoaneurysm
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 回顾性分析单中心血管内治疗创伤性颈内动脉颅内段假性动脉瘤(TIICAP)的安全性及临床疗效。方法 连续回顾2005年9月至2019年9月我中心收治的经脑血管造影检查的颅内动脉瘤患者资料,根据纳入标准选择TIICAP患者。分析患者的手术策略及围手术期抗血小板药物治疗情况,并总结治疗效果和临床与影像学随访结果。结果 共入组29例TIICAP患者,男19例(65.5%),女10例(34.5%),年龄为14~70岁,中位年龄为47(30,53)岁。29例患者均成功实施血管内治疗,其中采用覆膜支架3例,血流导向装置9例,支架辅助弹簧圈栓塞11例,单纯弹簧圈栓塞2例,载瘤动脉闭塞4例。1例行载瘤动脉闭塞患者术前再出血,术后死亡;1例行载瘤动脉闭塞患者术后发生缺血性脑卒中,最终死亡;余27例患者均无并发症发生,顺利出院。23例患者接受影像学随访,13例治愈,5例好转,2例稳定,3例复发(均再次行血管内治疗治愈)。24例患者接受临床随访,临床预后均稳定或好转。结论 血管内治疗是处理TIICAP的有效手段,其中血流导向装置、覆膜支架等新技术的优势初现,值得进一步研究。

    Abstract:

    Objective To retrospectively analyze the safety and clinical efficacy of endovascular treatment for traumatic intracranial internal carotid artery pseudoaneurysm (TIICAP) in a single center. Methods The data of patients with intracranial aneurysms, who underwent cerebral angiography from Sep. 2005 to Sep. 2019 in our Stroke Center, were reviewed consecutively. Patients with TIICAP were selected according to the inclusion criteria. The operative methods and perioperative antiplatelet drug treatment strategies were analyzed, and the therapeutic effect and clinical and imaging followup results were summarized. Results A total of 29 patients with TIICAP were enrolled, including 19 (65.5%) males and 10 (34.5%) females, with a median age of 47 (30, 53) years (range, 14-70 years). Endovascular treatment was successfully performed in the 29 cases, including 3 cases treated with covered stent implantation, 9 with flow diverter implantation, 11 with stent-assisted coiling embolization, 2 with coiling embolization and 4 with parent artery occlusion. One patient receiving parent artery occlusion suffered from rebleeding before operation, and died after operation. One patient receiving parent artery occlusion had ischemic stroke and died after operation. None of the remaining 27 patients had complications. Twenty-three patients were followed up by imaging. Thirteen of them were cured, 5 were improved, 2 were stable and 3 had recurrence, and the 3 recurrence cases were cured by endovascular treatment again. Twenty-four patients had clinical follow-up data, and the clinical outcomes were stable or improved. Conclusion Endovascular treatment is an effective method for TIICAP. The preliminary superiorities of novel techniques, including flow diverter and covered stent, deserve further confirmation.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-09-06
  • 最后修改日期:2020-12-18
  • 录用日期:
  • 在线发布日期: 2021-02-23
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭